DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Smits ML. et al.
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
Lancet Oncol 2012;
13: 1025-1034
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.